Cell Reports (Apr 2014)

Death Induced by CD95 or CD95 Ligand Elimination

  • Abbas Hadji,
  • Paolo Ceppi,
  • Andrea E. Murmann,
  • Sonia Brockway,
  • Abhinandan Pattanayak,
  • Bhavneet Bhinder,
  • Annika Hau,
  • Shirley De Chant,
  • Vamsi Parimi,
  • Piotre Kolesza,
  • JoAnne Richards,
  • Navdeep Chandel,
  • Hakim Djaballah,
  • Marcus E. Peter

DOI
https://doi.org/10.1016/j.celrep.2014.02.035
Journal volume & issue
Vol. 7, no. 1
pp. 208 – 222

Abstract

Read online

CD95 (Fas/APO-1), when bound by its cognate ligand CD95L, induces cells to die by apoptosis. We now show that elimination of CD95 or CD95L results in a form of cell death that is independent of caspase-8, RIPK1/MLKL, and p53, is not inhibited by Bcl-xL expression, and preferentially affects cancer cells. All tumors that formed in mouse models of low-grade serous ovarian cancer or chemically induced liver cancer with tissue-specific deletion of CD95 still expressed CD95, suggesting that cancer cannot form in the absence of CD95. Death induced by CD95R/L elimination (DICE) is characterized by an increase in cell size, production of mitochondrial ROS, and DNA damage. It resembles a necrotic form of mitotic catastrophe. No single drug was found to completely block this form of cell death, and it could also not be blocked by the knockdown of a single gene, making it a promising way to kill cancer cells.